Derivation Web

source_60a78f231ec246c1

by researka:v2 · 2026-05-27 18:12:39.029191+04:00

# Alpha memo — exercise

**Headline:** Pathway-specific anti-inflammatory gating: metformin unlocks TNF-axis suppression in exercise-responsive cancer survivors that exercise alone cannot achieve
**Confidence:** `evidence_backed_signal`
**Memo surface:** `alpha memo`
**Snapshot:** `2026-05-16T18-12-38Z`
**Run:** `exercise-evidence-2026-05-16T18-12-38Z`
**Direct source breadth:** `5` direct cited source(s)
**Source breadth:** `5/5` unique cited source(s)

## One-sentence thesis

The cited A/B receipts support a specific working claim: Compared with control, exercise alone reduced hs-CRP [-30.2%; 95% CI, -50.3, -1.0]; exercise alone reduced hs-CRP and IL6 (-30.9%; 95% CI, -47.3, -9.5). The cited receipts are separate evidence streams; this memo maps a testable contrast, not one integrated analysis.


**Interpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived claims require independent replication.

## Why this is surprising

The evidence pool reveals a recurring motif: exercise-induced molecular responses are pathway- and subgroup-specific rather than uniformly beneficial, yet nearly all studies report aggregate endpoints. The most publishable framing is not 'exercise reduces inflammation' but rather the divergence between which inflammatory axes (CRP/IL6 vs TNF-pathway vs angiocrine factors like PEDF/VEGF) are preferentially modulated by exercise alone versus combination interventions, and how this specificity is further distorted by obesity-related anabolic resistance and disease-state vascular dysfunction.

Known / obvious (do not republish): Exercise reduces inflammatory biomarkers in cancer survivors; Voluntary running reduces tumor growth in mouse xenograft models; Exercise capacity inversely correlates with mortality risk

Real tension: Exercise alone robustly reduces hs-CRP/IL6 (facts 6, 8: -30%) but does NOT reduce sTNFαR2; only the exercise+metformin arm achieves sTNFαR2 reduction (fact 5: -13.1%), suggesting metformin unlocks a TNF-pathway gate that exercise cannot breach alone — yet both interventions share the same cancer sur

## Evidence receipts

- `fact_id=22116` (`A_core`) — Compared with control, exercise alone reduced hs-CRP [-30.2%; 95% CI, -50.3, -1.0] doi=10.1158/1940-6207.capr-20-0188
- `fact_id=22117` (`A_core`) — exercise alone reduced hs-CRP and IL6 (-30.9%; 95% CI, -47.3, -9.5) doi=10.1158/1940-6207.capr-20-0188
- `fact_id=22118` (`A_core`) — exercise and metformin reduced sTNFαR2 and IL6 (-38.7%; 95% CI, -52.3, -18.9) doi=10.1158/1940-6207.capr-20-0188
- `fact_id=22119` (`A_core`) — exercise and metformin reduced sTNFαR2 (-13.1%; 95% CI, -22.9, -1.0) doi=10.1158/1940-6207.capr-20-0188
- `fact_id=12572` (`A_core`) — Mixed-muscle protein fractional synthetic rate increased by 42% at 3 h postexercise and 69% at 24 h postexercise in CON. doi=10.1152/ajpendo.00600.2013
- `fact_id=41245` (`A_core`) — tumor-bearing mice with access to running wheels showed reduced growth of MDA-MB-231 (-66%, P < 0.01) tumors doi=10.1158/0008-5472.can-16-3125
- `fact_id=12544` (`A_core`) — Mortality risk was 11% lower (hazard ratio, 0.89; 95% confidence interval, 0.86-0.93; P<0.001) for every 1-MET increase in exercise capacity. doi=10.1161/hypertensionaha.114.03510
- `fact_id=30392` (`A_core`) — IGF-I/IGFBP-3 ratio increased significantly in the diet + exercise group (+5.4%, P < 0.01) compared with control. doi=10.1158/1055-9965.epi-13-0337

## What this changes

Treat this as a focused working signal, not a broad topic claim. It moves review attention from a generic Top 5 list to the specific contrast, receipt bundle, and matched direct-receipt table by population, model, endpoint, comparator, and effect direction that could confirm or kill the thesis.

## Limitations

- This is an alpha memo, not a settled review, guideline, or broad consensus claim.
- This memo synthesizes cited source receipts; it does not conduct a new meta-analysis or systematic review.
- Interpret the thesis only within the cited receipt bundle and the explicit weakening checks below.
- Independent receipts fail to reproduce the claimed contrast.
- The effect depends on one protocol, subgroup, comparator, or extraction artifact.

## What would weaken this

- Independent receipts fail to reproduce the claimed contrast.
- The effect depends on one protocol, subgroup, comparator, or extraction artifact.

## Strongest counter-evidence

- _No A_core/B_context counter-evidence found in this run; treat this as a single-direction signal until a broader receipt expansion finds a real opposing fact._

## Next extraction

- Extract independent A_core/B_context receipts that test the lead contrast directly.
- Audit whether each direct receipt remains comparable on population, endpoint, comparator, and measurement method.

## Provenance / priority

- **Topic:** `exercise`
- **Author:** Dom Lynch
- **ORCID:** _not configured_
- **Version:** 1.0
- **License:** CC BY-NC 4.0
- **Canonical URL:** _not assigned_
- **Suggested citation:** Dom Lynch. (2026). Pathway-specific anti-inflammatory gating: metformin unlocks TNF-axis suppression in exercise-responsive cancer survivors that exercise alone cannot achieve. ReseaRka Evidence Index. Version 1.0.
- **Run bundle SHA-256:** `fe487b28cd8297287f8c8def5605a5aac25b0a1723c07436f22dfdaea7dc6374`
- **Memo SHA-256:** `1d14542b79ed2c1a30e08f424e4258955fc404c1b7ada06329e6c48607327a0c`
- **Priority note:** This memo records the first published framing, source bundle, and evidence receipts for this run. Reuse should cite the canonical version.

{
  "article_type": "alpha_memo",
  "domain_slug": "general",
  "researka_object_type": "submission",
  "researka_submission_id": "1e1e6dcc-b2fa-4ec6-86a8-f32239037373",
  "title": "Pathway-specific anti-inflammatory gating: metformin unlocks TNF-axis suppression in exercise-responsive cancer survivors that exercise alone cannot achieve"
}